Skip to main content
OpenTrials
Completed

NCT Number: NCT03055676

Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy

The aim of this randomized prospective multicenter study is to demonstrate the hypothesis that early removal of drain could reduce the incidence of major complications (grade 2-4) after pancreaticoduodenectomy (PD) , when compared with later removal of drain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Peking Union Medical College Hospital

Beijing, 100730, China

About this study

The objective of this randomized prospective multicenter study is to investigate the association between the time of removal of drain after pancreaticoduodenectomy (PD) and incidence of major complications (grade 2-4 complications). The investigators unite six pancreatic surgery center in Beijing. Patients who underwent pancreaticoduodenectomy (PD) or pylorus-preserving pancreaticoduodenectomy (PPPD) with low to moderate risk of post-operative pancreatic fistula (POPF) are recruited into the study. After obtaining informed consent, eligible patients are randomly allocated to early or late drain removal group on POD 3. In the group A, drain(s) are removed on POD 3, whereas in group B drain is removed on POD 5 or beyond. The primary outcomes are the incidence of sum of grade 2-4 complications, the secondary outcomes include grade B/C POPF, intra-abdominal infeciton, delayed gastric emptying, post-operative bleeding, in-hospital stay, total medical cost and comprehensive complication index (CCI).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • PD with or without pylorus preserving;
  • Age between 18 and 75 years;
  • Drain amylase on POD 1 and 3 less than 5000 U/L;
  • Drain output within POD 3 less than 300 ml per day.

Exclusion criteria

  • Vascular reconstruction using an artificial graft;
  • Grade B/ C postoperative bleeding, evident anastomosis leakage within 3 days after surgery;
  • Refusale to participate in after signed informed consent.

Treatment and study plan

Early drain removal

Other

Removing drain(s) on postoperative day 3

Late drain removal

Other

Removing drain(s) on postoperative day 5 or later

Primary outcomes

  1. The sum of grade 2- 4 complications

    Time frame: Up to postoperative 90 days

    The severity of complication was measured by Clavein Dindo classifications and grade 2- 4 complications always affect the recovery of the patients significantly.However, the death case (grade 5 complication) is rare now for PD in high volume centers. According to our single center study, early drain removal could reduce the rate of grade 2-4 complications by 12% for the patients undergoing major pancreatectomy.

Secondary outcomes

  1. Intra-abdominal bleeding

    Time frame: Up to postoperative 90 days

    The International Study Group of Pancreatic Surgery (ISGPS) definition: Blood loss through abdominal drains or nasogastric tube;hematemesis or melena; clinical deterioration of the patient; unexplained hypotension or tachycardia; or laboratory findings such as a decreasing hemoglobin concentration.

  2. Delayed gastric emptying

    Time frame: Up to postoperative 90 days

    The International Study Group of Pancreatic Surgery (ISGPS) definition: Inability to return to a standard diet by the end of the first postoperative week with prolonged nasogastric intubation.

  3. Grade B/C complications

    Time frame: Up to postoperative 90 days

    The International Study Group of Pancreatic Surgery (ISGPS) definition

  4. Length of hospital stay (day)

    Time frame: Up to postoperative 90 days

    Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.

  5. Comprehensive complication index (CCI)

    Time frame: Up to postoperative 90 days

    integrates all complications of the Clavien-Dindo classification (CDC) and offers a metric approach to measure morbidity.

  6. Interventional treatment

    Time frame: Up to postoperative 90 days

    interventional treatment for any complication.

  7. Total medical expenses

    Time frame: Up to postoperative 90 days

    Total medical expenses during hospitalization.

  8. Any other single intem of grade 2-4 complication

    Time frame: Up to postoperative 90 days

    Clavein Dindo Classification is adopted.

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Collaborators

  • Beijing Chao Yang Hospital
  • Beijing Tongren Hospital
  • Chinese Academy of Medical Sciences
  • Chinese PLA General Hospital
  • Peking University First Hospital
  • Xuanwu Hospital, Beijing

Registry information

Official study title

A Randomized Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Feb 16, 2017
Registry last updated
Apr 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.